Literature DB >> 3815199

Long-term follow-up of ophthalmic Graves' disease.

P J Agapitos, I R Hart.   

Abstract

Sixteen patients with ophthalmic Graves' disease (clinically euthyroid with ophthalmopathy or exophthalmos) were followed up for 4.3 to 14.3 (mean 9.1) years to determine whether thyroid dysfunction developed and whether their ophthalmopathy progressed, regressed or remained stable. Five patients (31%) manifested hyperthyroidism or hypothyroidism, all before the end of the fifth year of follow-up. The ophthalmopathy was mild, and none of the patients required specific treatment. The thyroid function of patients with ophthalmic Graves' disease should be periodically monitored for at least 5 years.

Entities:  

Mesh:

Year:  1987        PMID: 3815199      PMCID: PMC1492080     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Ophthalmic Graves' disease. Diagnosis and pathogenesis.

Authors:  R Hall; K Kirkham; D Doniach; D el-Kabir
Journal:  Lancet       Date:  1970-02-21       Impact factor: 79.321

Review 2.  Humoral factors in the pathogenesis of Graves' disease.

Authors:  J M McKenzie
Journal:  Physiol Rev       Date:  1968-01       Impact factor: 37.312

3.  Modification of the classification of the eye changes of Graves' disease.

Authors:  S C Werner
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

4.  Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy.

Authors:  G T Gamblin; D G Harper; P Galentine; D R Buck; B Chernow; C Eil
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

5.  Changes in thyroid functions in patients with euthyroid Graves' disease.

Authors:  H Tamai; T Nakagawa; N Ohsako; O Fukino; H Takahashi; F Matsuzuka; K Kuma; S Nagataki
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

6.  Response to thyrotropin-releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease.

Authors:  P S Franco; J M Hershman; E D Haigler; J A Pittman
Journal:  Metabolism       Date:  1973-11       Impact factor: 8.694

7.  Ophthalmopathy associated with primary hypothyroidism.

Authors:  B E Brownlie; O A Newton; S P Singh
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

8.  Ophthalmic Graves's disease: natural history and detailed thyroid function studies.

Authors:  C S Teng; P P Yeo
Journal:  Br Med J       Date:  1977-01-29

9.  Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography.

Authors:  J V Forrester; G R Sutherland; I R McDougall
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

10.  Euthyroid endocrine ophthalmopathy: a study of the pituitary-thyroid system.

Authors:  J Földes
Journal:  Acta Med Acad Sci Hung       Date:  1975
View more
  6 in total

1.  Aqueous misdirection in thyroid eye disease.

Authors:  Devjyoti Tripathy; Aparna Rao; Aniruddha Banerjee; Debananda Padhy
Journal:  BMJ Case Rep       Date:  2014-11-20

Review 2.  Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?

Authors:  P Anagnostis; K Boboridis; F Adamidou; M Kita
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

3.  The effect of subtotal thyroidectomy on Graves' ophthalmopathy.

Authors:  M D Levitt; A J Edis; R Agnello; C C McCormick
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

4.  Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question.

Authors:  Elena Sabini; Marenza Leo; Barbara Mazzi; Roberto Rocchi; Francesco Latrofa; Marco Nardi; Paolo Vitti; Claudio Marcocci; Michele Marinò
Journal:  Eur Thyroid J       Date:  2017-06-26

5.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

6.  Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States.

Authors:  Yao Wang; Anu Sharma; Lissa Padnick-Silver; Megan Francis-Sedlak; Robert J Holt; Colleen Foley; Guy Massry; Raymond S Douglas
Journal:  Ophthalmol Ther       Date:  2020-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.